August 31, 2011 Chance are good that you consumed something sugary (or high fructose corn syrupy) in the last day. On any particular day, half the people in the U.S. drink a soda, fruit or sports drink, or similar calorie-rich beverage.
August 29, 2011 Chocolate still isn't proven to prevent heart disease, stroke, and diabetes. But people who eat a lot of it are less likely to have those health problems, according to a new study in the British Medical Journal. The fat and sugar in chocolate treats may negate any health benefits in chocolate.
August 25, 2011 The FDA says doctors should not treat patients with doses of the antidepressant Celexa in excess of 40 milligrams a day. Doses higher than that raise the risk for abnormal heart rhythms.
The standard technique for measuring blood pressure may not be good enough.
August 24, 2011 Britain's health-quality institute says the good old blood pressure cuff is no longer good enough to accurately diagnose hypertension. The British now recommend that people with a high reading should also have an ambulatory test, wearing a blood-pressure monitor for 24 hours.
August 23, 2011 In just five years hospitals and doctors across the country have made remarkable progress in speeding up treatment. The median time for patients to get a potentially life-saving treatment dropped to 64 minutes in 2010 from 96 minutes in 2005.
August 20, 2011 Former President Bill Clinton was once renowned for his love of all foods fried and greasy. In the past year, he has gone meat- and dairy-free in an effort to fend off heart disease – and dropped more than 20 pounds. Quite a turnaround for a guy whose penchant for McDonald's was immortalized in a famous comedy skit.
A new drug called rivaroxaban may not require as many blood tests for patients with atrial fibrillation as the current drug on the market does.
August 10, 2011 Pharmaceutical companies have been working hard to make drugs to elbow out warfarin as the stroke-prevention drug for 2.3 million Americans with atrial fibrillation. A new study finds one of the contenders, rivaroxaban, is as effective as warfarin in preventing stroke, and doesn't require monitoring.
<iframe src="http://www.npr.org/player/embed/139402588/139519298" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
August 5, 2011 As many as 70 percent of 8-month-old babies consumed too much sodium, according to a study in the U.K. Many infants are eating the wrong kinds of foods — like canned, processed fare, researchers say. But even seemingly healthful options like bread and cereals can be loaded with salt.
August 2, 2011 Even modest amounts of physical activity reduce the dangers of heart disease, a new analysis finds. And the biggest benefits come from doing something rather than nothing.
A closeup of a Johnson & Johnson Cypher stent. The company, the first to market such devices, said last month it will get out of the stent business.
July 6, 2011 An analysis of treatments for more than a half-million heart patients found many got stents when standardized criteria suggested they were unwarranted. There were also wide variations in treatment approaches by hospital.
June 22, 2011 People taking high doses of statins were more likely to develop diabetes than those taking moderate doses of the drugs. The increase amounted to 2 additional cases of diabetes per 1,000 patients taking high doses of the medicines compared with those getting lower doses.
Got olive oil?
June 16, 2011 French researchers found an association between liberal use of olive oil and a lower risk of stroke for elderly people. The findings suggest consumption of the oil could have a health benefit, but the claim needs to be proved in more rigorous study, other researchers say.
June 13, 2011 Doctors have been puzzled about why 40 percent of people who receive pacemakers to treat heart failure don't improve. A new analysis concludes that a patient's heart must beat out of sync quite a bit to make the devices worthwhile.
The FDA says the highest approved dose of simvastatin, the generic name for the cholesterol-lowering drug Zocor, has been linked to increased risk of muscle injury.
June 8, 2011 The agency says the highest approved dose of simvastatin has been linked to an increased risk of muscle injury, a risk that is greatest during the first year of use. The FDA is telling doctors not to prescribe the 80 milligram dose to new patients.
May 26, 2011 A federal study testing prescription-strength niacin as an add-on to cholesterol-lowering statins to prevent heart disease was stopped early because the niacin did not work. There was also a slight increase in stroke risk for people taking the prescription-strength niacin.
<iframe src="http://www.npr.org/player/embed/136678665/136724412" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
NPR thanks our sponsors
Become an NPR sponsor